Afatinib Recruiting Phase 2 Trials for Non-Small Cell Lung Carcinoma (NSCLC) / Gastrointestinal Carcinoma, Non-colon / Upper Aerodigestive Tract Carcinoma / Transitional Cell Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02795156Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations